Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

GABAPENTIN CAPSULES

Active
SPE2DP-26-T-4457Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

GABAPENTIN CAPSULES, 100 MG in units of 100s, are procured under solicitation SPE2DP-26-T-4457 with a total requirement of 7,000 capsules across two line items, each with a 0% quantity variance. The item is regulated by the FDA and must comply with the DLA Master List of Technical and Quality Requirements, including shelf-life specifications of 36 months non-extendable for TYPE I (CODE Q) items. Packaging must meet Commercial standards and Medical Marking Standard No. 1, superseding MIL-STD-129, with all labeling and palletization aligned to RP001 and DLA packaging directives. Storage must maintain 25°C (77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F) per USP Controlled Room Temperature. The material is not classified as hazardous under FED-STD-313 and must be commercially packaged in accordance with ASTM D3951, though DLA requirements override any conflicting standards. Delivery is FOB destination with a five-day lead time and inspection and acceptance occurring at the destination point. The items are to be shipped via traceable means, not parcel post, to the USS MAKIN ISLAND LHD 8 at FPO AP 96672, with a required delivery date of April 3, 2026. Manufacturers include MARLEX PHARMACEUTICALS INC, CIPLA USA INC, and SCIEGEN PHARMACEUTICALS INC, identified by their respective NDC codes. The unit of issue is BT (100s), with each unit pack containing one BT. All packaging and marking must reflect the correct NSN 6505013871892, and vendors must use the DLA VSM system for shipment tracking. Government use codes and contract identifiers are specified for administrative and logistical tracking, and all documentation must adhere to the latest DLA procedural notes for transportation, marking, and delivery verification.

General Info

100 mg gabapentin capsules, 7,000 units, FOB destination, delivery April 3, 2026, DLA packaging and storage standards apply.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

UNIT 100222 BOX 1, FPO, AP, 96672, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4457.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
JAMES MCCULLOUGH
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
GABAPENTIN CAPSULES
GABAPENTIN CAPSULES, 100 MG, 100S
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
U/I "BT" (100'S)
Store at 25C (77F); excursions permitted between 15C to 30C (59F to 86F) see USP Controlled Room Temperature. This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SPE2DP-26-T-4457
SECTION B
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
MARLEX PHARMACEUTICALS INC 1TAP7 P/N NDC10135-0644-01 SCIEGEN PHARMACEUTICALS INC 8NLP1 P/N NDC50228-0179-01 CIPLA USA INC 7WV84 P/N NDC69097-0813-07
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016153280 0001 BT 5.000
NSN/MATERIAL:6505013871892
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R23171
USS MAKIN ISLAND LHD 8
UNIT 100222 BOX 1
FPO AP 96672
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
SPE2DP-26-T-4457
SECTION B
PR: 7016153280 PRLI: 0001 CONT’D
FREIGHT SHIPPING ADDRESS:
R23171
USS MAKIN ISLAND LHD 8
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
M/F: (TCN) R231716089MH06
RDD: 777
PROJ: EP5 TP 1
SUPP ADD: YNMH01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 03
DIC: A4A DIST: 9B ADV: 2A FC: N7
Need Ship Date:00/00/0000 Original Required Delivery Date:04/03/2026
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0002 7016615962 0001 BT 2.000
NSN/MATERIAL:6505013871892
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING
SPE2DP-26-T-4457
SECTION B
PR: 7016615962 PRLI: 0001 CONT’D
REQUIREMENTS FOR PROCUREMENT
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-387-1892 Quantity: 5 BT Purchase Request: 7016615962QTY: 2 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
TOLNAFTATE POWDER, U
Solicitation # SPE2DP-26-T-4452
The contract specifies the procurement of Tolnaftate Powder, USP 1%, in 45-gram units, with a total quantity of 19 BT (each BT equaling 45 grams), supplied by Geri-Care Pharmaceuticals Corp. under part number NDC57896-0199-45 and NSN 6505014807897. Delivery is required within five days FOB destination, with no variance allowed in quantity, and inspection and acceptance occur at the delivery point. The product must comply with strict packaging and marking standards, including Medical Marking Standard No. 1, which replaces all references to MIL-STD-129, and must be packed in sealed unit containers and commercial shipping containers ensuring safe transport at the lowest carrier rate. The item is classified as a TYPE I (CODE Q) medical product with a non-extendable shelf life of 36 months. All packaging and labeling must adhere to DLA requirements outlined in the Master List of Technical and Quality Requirements, and covered defense information protocols apply. The solicitation, issued under SPE2DP-26-T-4452 with a response deadline of August 10, 2026, is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with point of contact Imerah Burnett at Offutt AFB, and the unit of issue follows DoD authorization with corresponding ANSI X12 alignment.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
LIDOCAINE HYDROCHLORID
Solicitation # SPE2DP-26-T-4454
Lidocaine hydrochloride and dextrose injection in 500 mL premixed bags, containing 0.4% lidocaine and 5% dextrose, is being procured under solicitation SPE2DP-26-T-4454 with a unit of issue defined as a package of 18 bags. The item must meet stringent technical and quality standards outlined in the DLA Master List of Technical and Quality Requirements, and packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129. At least 16 months of shelf life must remain at the time of delivery to the first government activity, as the product has a fixed 18-month non-extendable shelf life under Type I (Code K) requirements. The drug is regulated by the FDA, and contractors must ensure full compliance with all applicable federal standards for commercial packaging, including ASTM D3951 where applicable, though DLA requirements take precedence. The product is currently in limited supply due to manufacturing constraints, and only Baxter Healthcare Corp’s specific NDC 00338-0409-03 and part number 2B0973P are authorized. Delivery is required within five days of award, FOB destination, with zero variance permitted in quantity. The shipment must be sent via traceable and expedited means to the USS THEODORE ROOSEVELT CVN 71 at FPO AP 96632, using RDD 777 and VSM logistics protocols, and parcel post is strictly prohibited. Packaging must be palletized according to RP001 requirements and labeled in full compliance with DLA’s medical marking standards. The contract specifies a single purchase request quantity of one package, with a required delivery date of August 5, 2026, and procurement is managed by the Department of Defense’s Medical Supply Chain PHARM FSA. All bidders must provide detailed manufacturer and product information for FDA verification through EBS referral prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
SODIUM CHLORIDE IRRIGA
Solicitation # SPE2DP-26-T-4449
Sodium Chloride Irrigation, USP, is prescribed as a 0.9% solution in 250 mL plastic squeeze bottles, packaged 24 bottles per packing group, and must be stored at controlled room temperature of 25 degrees Celsius with protection from excessive heat. The product must comply with the DLA Master List of Technical and Quality Requirements, and its shelf life is fixed at 36 months without extension, classified as a Type I (Code Q) item. All packaging and labeling must adhere strictly to Medical Marking Standard No. 1, superseding MIL-STD-129, with documentation available via DLA Troop Support. Each unit must be sealed and protected from damage, and shipped in commercial exterior containers suitable for safe delivery by common carrier at the lowest cost to the designated destination. The item is identified by NSN 6505-01-253-8150 and NDC 00338-0048-02, supplied by Baxter Healthcare Corp, and is subject to a firm fixed price with zero variance allowed in quantity. Delivery is required FOB destination within five days of contract award, with inspection and acceptance occurring at the point of delivery. The contract is issued under solicitation SPE2DP-26-T-4449, with a response deadline of August 10, 2026, and falls under NAICS code 325412 for pharmaceutical preparation manufacturing. All data, including point of contact James Foggie and delivery location at Fort Bragg, NC, is governed by Federal procurement standards under the Department of Defense.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
BISMUTH SUBSALICYLA
Solicitation # SPE2DP-26-T-4459
The contract pertains to the procurement of Bismuth Subsalicylate Suspension, 262 mg per 15 mL, in 240 mL bottles, with a total order of two bottles. The item has a non-extendable shelf life of 24 months, and no more than 85 percent of that shelf life may have elapsed between the date of manufacture and the date of delivery to the government. Packaging must comply with commercial standards and meet the requirements of Medical Marking Standard No. 1, which supersedes MIL-STD-129; each unit must be sealed in a container that protects against damage, and all shipping containers must ensure safe, cost-effective delivery via common carrier to the designated destination. The product is regulated by the FDA and requires referral through EBS for confirmation by a product specialist, including full manufacturer and bidder details. Labeling, marking, and packaging must adhere strictly to the latest edition of Medical Marking Standard No. 1, accessible via the DLA website. Delivery is FOB destination within 20 days of contract award, with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. The item is identified by NSN 6505015056483, NDC 00536-1286-36, and is sourced from The Harvard Drug Group, L.L.C. under solicitation SPE2DP-26-T-4459, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, with performance at Fort Drum, NY.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
ARTIFICIAL TEARS SOLUT
Solicitation # SPE2DP-26-T-4455
The contract specifies the procurement of 20 packages of Artificial Tears Solution, each package containing 30 single-dose vials of 0.3 mL, for a total of 600 vials. The item is regulated by the FDA and has a non-extendable shelf life of 24 months, adhering to RS001 for TYPE I (CODE M) items. Packaging must comply with the Medical Marking Standard No. 1, superseding MIL-STD-129, and all units must be hermetically sealed and protected against damage, packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost. The product, manufactured by Allergan Inc with NDC 00023-4554-30, must be labeled and marked per DLA specifications and is not considered hazardous under Fed-Std-313, requiring commercial packaging consistent with ASTM D3951 unless superseded by higher-priority DLA technical requirements. Delivery is FOB destination within five days of order, with zero tolerance for quantity variance, and must be shipped by traceable means—parcel post is prohibited. The shipment is destined for USS THEODORE ROOSEVELT CVN 71, FPO AP 96632, with a required delivery date of August 5, 2026, and must include all applicable DLA packaging and labeling standards including palletization per RP001. The contracting official must submit an EBS referral for FDA confirmation, including manufacturer and product details.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
LIDOCAINE HYDROCHLORID
Solicitation # SPE2DP-26-T-4451
This contract specifies the procurement of 2 units of Lidocaine Hydrochloride and Epinephrine Injection, USP, each unit containing 50 cartridges of 1.7 mL with a concentration of 2% Lidocaine Hydrochloride and a 1:100,000 ratio of Epinephrine. The product is designated for local dental anesthesia via nerve block or infiltration only, must be stored at controlled room temperature below 25°C, protected from light, and must not be permitted to freeze. The item is latex-free and regulated by the FDA. A minimum of 13 months of remaining shelf life is required upon receipt by the first government activity, with a total shelf life of 15 months that is non-extendable. All packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must be suitable for commercial shipping with protection against damage and breakage. Packaging must conform to ASTM D3951 unless otherwise overridden by DLA’s Master List of Technical and Quality Requirements, and hazardous material protocols under FED-STD-313 must be followed if applicable. Units are packed as 50 cartridges per unit of issue (PG), and palletization must meet DLA’s procurement packaging standards. Delivery is required FOB destination within 20 days of contract award to Joint Base Charleston, SC, and must be shipped via traceable logistics—parcel post is prohibited. The contract is issued under solicitation SPE2DP-26-T-4451 with a response deadline of August 10, 2026, and the item’s NSN is 6505-01-597-1328. Approved manufacturers include Henry Schein, Inc., Benco Dental Supply Co., and Darby Dental Supply, LLC, with specific part and NDC numbers listed. All documentation and labeling must strictly adhere to DLA requirements and FDA regulations.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
CHLORINE TEST REAGE
Solicitation # SPE2DS-26-T-302D
The contract pertains to the procurement of 65 packages of chlorine test reagent, each package containing 100 powder pillows sufficient for 10 mL sample testing, identified by NSN 6550-01-460-7597. The item must comply with strict technical and quality standards referenced in the DLA Master List of Technical and Quality Requirements and adhere to DLA packaging and medical marking standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transport via common carrier at the lowest rate to the delivery point in FPO, with all labeling conforming to MMS1C guidelines, including clear markings for date of manufacture, expiration or retest date, and contract or lot number. The reagent has a non-extendable shelf life of 60 months, and delivery to the Government must occur with no more than 8 months having elapsed since the date of manufacture. The solicitation, issued under contract number SPE2DS-26-T-302D, requires response by August 10, 2026, with a delivery deadline of 5 days after award. The item is classified as a TYPE I (CODE S) medical supply, subject to all applicable medical procurement regulations, and the packaging must meet commercial standards as specified. The contracting office is part of the Department of Defense’s Medical Supply Chain under the Medical Supply Chain MD SURG FSF, with Seth Tootell listed as the primary point of contact for inquiries.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
CYCLOSPORINE OPHTHA
Solicitation # SPE2DP-26-T-4453
Cyclosporine Ophthalmic Ointment, 0.2% per gram, in a 3.5 gram sterile, preservative-free tube, is designated for veterinary use in managing keratoconjunctivitis sicca in dogs. The unit of issue is a package containing six tubes, and the product must be stored at controlled room temperature. It is subject to strict packaging standards per the latest Medical Marking Standard No. 1 and requires marking in accordance with MMS No. 1B dated 30 March 2017. The item has a non-extendable shelf life of 24 months under RS016 compliance. The product is supplied by multiple manufacturers including Merck Sharp & Dohme LLC, Patterson Veterinary Supply, Inc., and Penn Veterinary Supply Inc., each with their respective part numbers and NDC codes. This item is procured under the Department of Defense with NSN 6509-01-530-4765 and purchase request 7017723033, with a contract solicitation number SPE2DP-26-T-4453. Delivery is scheduled for 89 days after award, FOB destination, with zero variance permitted in quantity, and inspection and acceptance occur at the destination. Packaging must meet MIL-STD-2073-1E specifications, and defense information handling requirements apply. The point of contact for the solicitation is Shairy M. Cartagena at the Medical Supply Chain Pharm FSA under the DLA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
WATER FOR IRRIGATION, S
Solicitation # SPE2DP-26-T-4458
Water for Irrigation, Sterile, USP, is a sterile, distilled, nonpyrogenic solution intended exclusively for irrigation, washing, rinsing, and dilution purposes and is not for injection by any parenteral route. Each unit is a 1000 mL semi-rigid plastic container with a screw cap, available with or without a hanging device, and is packaged in cases of 12 units per package, the unit of issue. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from freezing and excessive heat, and has a non-extendable shelf life of 36 months. It is regulated by the FDA and must be marked in compliance with the latest edition of Medical Marking Standard No. 1 and labeled according to MIL-STD-129. Packaging must adhere to DLA’s RP001 requirements and ASTM D3951 for non-hazardous materials, with DLA’s technical and quality requirements overriding any conflicting standards. The item is identified by NSN 6505-01-075-0679 and NDC 00338-0004-04, manufactured by Baxter Healthcare Corporation. The contract specifies delivery of two packages totaling 24 units, with delivery due within 20 days to two separate destinations: USS William P Lawrence DDG 110 and USS Zumwalt DDG 1000, FOB destination. Inspection and acceptance occur at the delivery point, with zero variance permitted in quantity. Shipping must use traceable transport methods, and parcel post is prohibited. All requirements, including those from the DLA Master List of Technical and Quality Requirements, must be strictly followed, and the solicitation, issued by the Department of Defense, has a response deadline of August 10, 2026, with a contract award anticipated in support of military medical supply needs.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LAC
Solicitation # SPE2DP-26-T-4450
RINGER’S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per package, is procured under contract SPE2DP-26-T-4450 with a delivery requirement of 20 days FOB destination. The item is regulated by the FDA and requires prior confirmation by a product specialist through EBS referral, including full bidder and manufacturer details such as B. BRAUN MEDICAL INC, part number L7500, and NDC 00264-7750-00. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transport via common carrier at the lowest cost. All packaging and labeling must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and must be marked according to the latest edition of MMS NO. 1, accessible via DLA’s website. The product has a non-extendable shelf life of 30 months and must be stored at or near room temperature (25°C), with brief exposure to 40°C permitted without degradation. Inspection and acceptance occur at the destination, with zero tolerance for quantity variance. The unit of issue is one package (PG), equal to 12 units, and the NSN is 6505013306267. Technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date. Delivery is to Gastonia, NC, and the contracting office is under the Department of Defense’s Medical Supply Chain.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
International
ACAN tecovirimat
Solicitation # WS5801165980
Public Services and Procurement Canada is preparing to award a contract to SIGA Technologies Inc for the supply of tecovirimat, an antiviral drug used to treat human smallpox, on behalf of the Department of National Defence and the Public Health Agency of Canada. This notice serves as an Advanced Contract Award Notice, indicating the government’s intent to proceed with SIGA Technologies Inc as the selected supplier unless another qualified supplier submits a statement of capabilities by the deadline. The solicitation number is WS5801165980, posted on August 3, 2026, with responses due by August 18, 2026. The NAICS code 325412 identifies the industry as pharmaceutical and medicine manufacturing, and the contract is classified as a federal procurement. The primary point of contact for inquiries is Anja Ramenason, Contracting Authority, reachable via email at anja.ramenason@tpsgc-pwgsc.gc.ca. The place of performance is within Canada, and all interested suppliers must submit their capabilities by the closing date to be considered, otherwise the award will proceed as planned with the pre-identified supplier.
Department of Public Works and Government Services

POSTED

about 21 hours ago

DEADLINE

in 15 days
View Details
NAICS: 325412
New
DIBBS
Surgical Lubricant SupplyThe contract entails the supply of surgical-grade lubricant packaged and labeled in strict compliance with military standards for use across Department of Defense medical facilities. The product must meet stringent quality requirements to ensure safety and effectiveness in clinical settings, and all packaging must adhere to specified military specifications for durability, traceability, and handling in austere environments. The place of performance is designated as APO with a zip code of 09094-3219, indicating delivery to deployed or overseas military medical units. The NAICS code 325412 identifies the industry as pharmaceutical and medicinal product manufacturing, confirming the technical nature of the goods required. The solicitation was posted on August 2, 2026, with a response deadline of August 10, 2026, and the contract type is classified as a subcontract, suggesting it is part of a larger procurement chain managed by the Medical Supply Chain Pharm FSA under the Department of Defense. The requirement does not include a set-aside designation, meaning all eligible vendors may compete regardless of business size or status. All bids must align precisely with DoD packaging and labeling protocols to ensure seamless integration into existing logistics and inventory systems within military healthcare operations.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 7 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325411
New
DIBBS
MAGNESIUM SULFATE
Solicitation # SPE2DP-26-T-4456
MAGNESIUM SULFATE 495MG/5GM oral granules in 454GM bags, sold in cases of 12 bags each, is procured under contract SPE2DP-26-T-4456 for delivery to the USS THEODORE ROOSEVELT CVN 71 at FPO AP 96632 with a five-day delivery window and no tolerance for quantity variance. The product is classified as a TYPE I (CODE Q) medical item with a non-extendable shelf life of 36 months and must comply with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. All packaging must meet commercial standards as specified in DLA’s procurement requirements, ensuring each unit is sealed in protective containers and packed in exterior shipping containers suitable for safe, low-cost transport by common carrier to the destination. Palletization and labeling must adhere to DLA’s Packaging Requirements for Procurement and the latest version of Medical Marking Standard No. 1, available through DLA Troop Support or their official website. The item is identified by NSN 6505-01-714-4975 and NDC 46122-0461-43, supplied by AMERISOURCEBERGEN DRUG CORP, and shipped via traceable methods only—parcel post is prohibited. Delivery is FOB destination with inspection and acceptance also occurring at the point of delivery, and the required delivery date is August 5, 2026.
Medicinal and Botanical Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325998
New
DIBBS
WATER PURIFICATION TAB
Solicitation # SPE2DP-26-T-4448
The contract specifies the procurement of 200 units of water purification tablets containing stabilized chlorine dioxide, with no active chlorine or iodine, designed for military use in first aid kits. Each unit, designated as PG, contains ten individually sealed tablets and must meet a strict 60-month shelf life, with at least 51 months remaining upon delivery to the government. The product, identified by NSN 6850-01-530-3396 and part number 8014821 from KATADYN NORTH AMERICA INC., is subject to the Hazard Communication Standard as revised under OSHA’s alignment with the Globally Harmonized System, requiring suppliers to submit approved Safety Data Sheets and compliant labels prior to award, along with employee training on updated hazard communication protocols. Packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and comply with MIL-STD-2073-1E for protective sealing and shipping containers suitable for common carrier transport at the lowest cost to the destination point of APO with ZIP 96260-5479. Delivery is required within 84 days FOB destination, with zero tolerance for quantity variance, and inspection and acceptance occur at the point of delivery. The item is classified as a TYPE I (CODE S) under shelf-life requirement RS001, which prohibits extension beyond the 60-month limit. All technical and quality requirements referenced are governed by the DLA Master List, and the solicitation number SPE2DP-26-T-4448 governs procurement terms under a federal acquisition vehicle.
All Other Miscellaneous Chemical Product and Preparation Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 488510
New
DIBBS
International Medical Supply Logistics and DeliveryThe contract requires the arrangement and execution of international shipping for medical supplies destined for Ramstein Air Base, with full responsibility for export packaging, customs clearance, and final-mile delivery to the specified military location. All logistics must comply with international shipping regulations and U.S. Department of Defense standards, ensuring secure, timely, and traceable transport of sensitive medical materials. The place of performance is designated as APO 09094-3219, indicating delivery to a U.S. military installation overseas, and the work falls under NAICS code 488510 for support activities for air transportation. This is a subcontract opportunity posted by the Medical Supply Chain Pharm FSA under the Department of Defense, with a response deadline of August 10, 2026. The solicitation is open to qualified providers capable of handling the complexities of global medical logistics, including documentation for export compliance, coordination with foreign customs authorities, and guaranteed delivery to a U.S. military facility. Bidders must demonstrate experience in high-stakes, time-sensitive medical supply chains and possess the infrastructure to support end-to-end logistics from origin through final delivery without disruption.
Freight Transportation Arrangement

POSTED

1 day ago

DEADLINE

in 7 days
View Details